Overview

This trial is active, not recruiting.

Condition juvenile idiopathic arthritis
Treatment virtual peer-to-peer support mentoring
Sponsor The Hospital for Sick Children
Start date July 2013
End date May 2015
Trial size 40 participants
Trial identifier NCT01986400, 1000038163

Summary

Study Hypothesis: A virtual peer-to-peer support intervention will improve health outcomes and quality of life in adolescents with Juvenile Idiopathic Arthritis

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking single blind (outcomes assessor)
Primary purpose health services research
Arm
(Experimental)
In addition to standard medical care, adolescents in the experimental group will receive the VP2P support program, a manualized peer-mentorship program that will provide modeling and reinforcement by peers (young adults with JIA aged 16-25 years who have learned to function successfully with their JIA to the mentored participants).
virtual peer-to-peer support mentoring
The mentorship program will encourage mentored participants to develop and engage in self-management and transition skills and support their practice of these skills. The mentors will present information to mentored participants in a monitored virtual interaction using Skype for 8 weeks (10 total Skype sessions of 30-60 minutes each) to encourage participation in skill building tailored to their needs. All mentors will complete a paid 2.5 day training course and will be supported throughout the duration of the study (consultations with research staff to deal with unforeseen concerns). Mentored participants will complete online outcome measures prior to randomization (T1) and upon study completion (T2).
(No Intervention)
The control group will receive usual care but without the mentorship intervention. They will be offered the VP2P support program after completion of outcome measures (T1 - to be completed online prior to randomization; T2 - at program completion).

Primary Outcomes

Measure
Feasibility
time frame: 2 months

Secondary Outcomes

Measure
Health-Related Quality of Life (HRQL)
time frame: Baseline, 2 months
Pain
time frame: Baseline, 2 months
Knowledge and Social Support
time frame: Baseline, 2 Months
Self-Efficacy
time frame: Baseline, 2 Months
Adherence
time frame: Baseline, 2 Months

Eligibility Criteria

Male or female participants from 12 years up to 18 years old.

Inclusion Criteria: - males and females 12-18 years old - diagnosed with Juvenile Idiopathic Arthritis (JIA) by a Rheumatologist (any sub-type) - able to speak and read English - access to Internet connection, computer capable of using free Skype software - willing and able to complete online measures Exclusion Criteria: - significant cognitive impairments - major co-morbid illnesses (i.e., psychiatric conditions) likely to influence HRQL assessment - participating in peer support or self-management interventions (e.g., Teens Taking Charge).

Additional Information

Official title Virtual Peer-to-Peer Support Mentoring for Adolescents With Juvenile Idiopathic Arthritis: A Feasibility Pilot Randomized Controlled Trial
Principal investigator Jennifer N Stinson, RN,PhD,CPNP
Description The aim of this project is to develop and examine the impact of a virtual peer support program on health outcomes and quality of life of adolescents with Juvenile Idiopathic Arthritis using a waitlist randomized controlled trial. In addition to standard medical care, adolescents in the experimental group will receive a manualized peer mentorship program that will provide modeling and reinforcement by trained young adults aged 16-25 years who have learned to function successfully with their pain. Mentoring sessions consist of 10 sessions of 30-45 minute Skype calls over 8 weeks. Feasibility of the program will be measured in addition to quality of life, physical and emotional symptoms, pain coping, self-efficacy, social support, and self-management skills.
Trial information was received from ClinicalTrials.gov and was last updated in April 2016.
Information provided to ClinicalTrials.gov by The Hospital for Sick Children.